Kyverna Therapeutics (KYTX) Institutional Ownership

$8.95 +0.78 (+9.55%)

Closing price 08/17/2026 04:00 PM Eastern

Extended Trading

$8.89 -0.06 (-0.67%)

As of 08:08 AM Eastern

Compare

Current Institutional Ownership Percentage: 18.08%
Number of Institutional Buyers (last 12 months): 63
Total Institutional Inflows (last 12 months): $154.98M

Number of Institutional Sellers (last 12 months): 14
Total Institutional Outflows (last 12 months): $9.26M

Get KYTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kyverna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/17/2026	Bank of America Corp DE	265,405	$2.37M	0.0%	N/A	0.429%
8/15/2026	Man Group plc	68,640	$612K	0.0%	N/A	0.111%
8/14/2026	Canada Pension Plan Investment Board	40,000	$356K	0.0%	N/A	0.065%
8/14/2026	Legal & General Group Plc	4,072	$36K	0.0%	N/A	0.007%
8/14/2026	The Manufacturers Life Insurance Company	82,207	$732K	0.0%	N/A	0.133%
8/12/2026	Quantbot Technologies LP	21,287	$190K	0.0%	N/A	0.035%
8/7/2026	BlackRock Inc.	3,134,807	$27.93M	0.0%	N/A	5.157%
8/7/2026	Deutsche Bank AG	44,853	$400K	0.0%	N/A	0.074%
8/7/2026	Mitsubishi UFJ Asset Management Co. Ltd.	25,741	$229K	0.0%	N/A	0.042%
8/7/2026	AIGH Capital Management LLC	2,795,797	$24.91M	1.6%	N/A	4.599%
Get the Latest News and Ratings for KYTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/6/2026	Bank of New York Mellon Corp	100,281	$894K	0.0%	N/A	0.165%
8/6/2026	State of Wyoming	10,849	$97K	0.0%	N/A	0.018%
8/3/2026	Walleye Capital LLC	245,587	$2.19M	0.0%	N/A	0.404%
5/19/2026	Bank of America Corp DE	55,728	$481K	0.0%	+94.1%	0.092%
5/18/2026	ADAR1 Capital Management LLC	22,428	$194K	0.0%	-60.9%	0.037%
5/15/2026	OMERS ADMINISTRATION Corp	14,800	$128K	0.0%	-57.5%	0.024%
5/14/2026	Renaissance Technologies LLC	367,492	$3.17M	0.0%	+106.6%	0.605%
5/14/2026	Walleye Capital LLC	38,196	$330K	0.0%	N/A	0.063%
5/6/2026	Kera Capital Partners Inc.	108,083	$933K	0.1%	-18.5%	0.179%
4/30/2026	AIGH Capital Management LLC	2,000,000	$17.26M	2.4%	+33.3%	3.304%
4/27/2026	Simplify Asset Management Inc.	173,106	$1.49M	0.0%	-10.0%	0.286%
4/27/2026	Y Intercept Hong Kong Ltd	114,841	$991K	0.0%	N/A	0.190%
4/21/2026	Wesbanco Bank Inc.	110,300	$952K	0.0%	N/A	0.182%
4/21/2026	Grey Ledge Advisors LLC	10,000	$86K	0.0%	N/A	0.017%
4/20/2026	Banque Cantonale Vaudoise	30,532	$263K	0.0%	N/A	0.050%
2/23/2026	Kera Capital Partners Inc.	132,603	$1.25M	0.2%	-68.6%	0.303%
2/18/2026	Empowered Funds LLC	17,935	$169K	0.0%	N/A	0.041%
2/18/2026	XTX Topco Ltd	23,282	$219K	0.0%	-52.6%	0.053%
2/18/2026	Quadrature Capital Ltd	57,369	$539K	0.0%	N/A	0.131%
2/18/2026	Millennium Management LLC	593,369	$5.58M	0.0%	+7.6%	1.355%
2/18/2026	Balyasny Asset Management L.P.	980,869	$9.22M	0.0%	N/A	2.239%
2/18/2026	683 Capital Management LLC	114,900	$1.08M	0.0%	N/A	0.262%
2/18/2026	ACT Capital Management LLC	25,100	$236K	0.2%	N/A	0.057%
2/17/2026	ADAR1 Capital Management LLC	57,428	$540K	0.0%	N/A	0.131%
2/17/2026	Schonfeld Strategic Advisors LLC	28,872	$271K	0.0%	N/A	0.066%
2/17/2026	Burkehill Global Management LP	200,000	$1.88M	0.1%	N/A	0.457%
2/17/2026	Bain Capital Life Sciences Investors LLC	3,110,000	$29.23M	2.2%	-7.7%	7.100%
2/17/2026	Jump Financial LLC	80,299	$755K	0.0%	N/A	0.183%
2/17/2026	Heights Capital Management Inc.	271,822	$2.56M	0.9%	N/A	0.621%
2/17/2026	Price T Rowe Associates Inc. MD	1,762,617	$16.57M	0.0%	+16.6%	4.024%
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
2/17/2026	Adage Capital Partners GP L.L.C.	1,666,666	$15.67M	0.0%	N/A	3.805%
2/16/2026	OMERS ADMINISTRATION Corp	34,800	$327K	0.0%	N/A	0.079%
2/16/2026	Squarepoint Ops LLC	138,868	$1.31M	0.0%	N/A	0.317%
2/16/2026	Maven Securities LTD	146,400	$1.38M	0.0%	N/A	0.334%
2/16/2026	Barclays PLC	164,668	$1.55M	0.0%	+116.1%	0.376%
2/13/2026	Marshall Wace LLP	135,600	$1.28M	0.0%	N/A	0.310%
2/13/2026	The Manufacturers Life Insurance Company	134,530	$1.26M	0.0%	+29.6%	0.307%
2/13/2026	Stifel Financial Corp	125,790	$1.18M	0.0%	+224.0%	0.287%
2/13/2026	Hudson Bay Capital Management LP	88,553	$832K	0.0%	N/A	0.202%
2/13/2026	Alyeska Investment Group L.P.	600,000	$5.64M	0.0%	N/A	1.370%
2/13/2026	Wells Fargo & Company MN	74,949	$705K	0.0%	+310.0%	0.171%
2/12/2026	Renaissance Technologies LLC	177,899	$1.67M	0.0%	+8.1%	0.406%
2/12/2026	Dimensional Fund Advisors LP	78,413	$737K	0.0%	N/A	0.179%
2/12/2026	EntryPoint Capital LLC	10,048	$94K	0.0%	N/A	0.023%
2/12/2026	Federated Hermes Inc.	20,705	$195K	0.0%	+36.6%	0.047%
2/12/2026	Monashee Investment Management LLC	195,000	$1.83M	1.0%	N/A	0.445%
2/11/2026	Empowered Funds LLC	17,935	$169K	0.0%	N/A	0.041%
2/11/2026	Propel Bio Management LLC	666,666	$6.27M	5.4%	N/A	1.522%
2/10/2026	TD Asset Management Inc	222,796	$2.09M	0.0%	+35.2%	0.509%
2/10/2026	Goldman Sachs Group Inc.	133,530	$1.26M	0.0%	+209.6%	0.305%
2/9/2026	Geode Capital Management LLC	266,402	$2.51M	0.0%	-4.3%	0.608%
2/9/2026	Simplify Asset Management Inc.	192,339	$1.81M	0.0%	N/A	0.439%
2/9/2026	Jefferies Financial Group Inc.	32,001	$301K	0.0%	+96.3%	0.073%
2/6/2026	Nano Cap New Millennium Growth Fund L P	53,500	$503K	0.4%	N/A	0.122%
2/3/2026	RFG Advisory LLC	445,200	$4.19M	0.1%	N/A	1.017%
2/2/2026	AIGH Capital Management LLC	1,500,000	$14.10M	3.4%	N/A	3.425%
1/28/2026	Peapod Lane Capital LLC	183,820	$1.73M	1.5%	-42.3%	0.420%
1/22/2026	Phoenix Wealth Advisors	12,300	$116K	0.0%	+17.1%	0.028%
1/1/2026	JPMorgan Chase & Co.	6,675	$40K	0.0%	-76.0%	0.015%
11/17/2025	Jacobs Levy Equity Management Inc.	147,712	$886K	0.0%	N/A	0.337%
11/17/2025	Woodline Partners LP	252,212	$1.51M	0.0%	N/A	0.576%
11/17/2025	Qube Research & Technologies Ltd	36,691	$220K	0.0%	+161.1%	0.084%
11/17/2025	Prelude Capital Management LLC	19,438	$117K	0.0%	-46.4%	0.044%
11/17/2025	Public Employees Retirement System of Ohio	4,600	$28K	0.0%	N/A	0.011%
11/17/2025	Millennium Management LLC	551,635	$3.31M	0.0%	+21.9%	1.259%
11/17/2025	Bank of America Corp DE	64,964	$390K	0.0%	+92.5%	0.148%
11/17/2025	Ameriprise Financial Inc.	12,882	$77K	0.0%	N/A	0.029%
11/14/2025	Two Sigma Investments LP	132,451	$795K	0.0%	+9.8%	0.306%
11/14/2025	Bridgeway Capital Management LLC	174,900	$1.05M	0.0%	+178.1%	0.404%
11/13/2025	UBS Group AG	157,422	$945K	0.0%	+60.4%	0.364%
11/13/2025	BNP Paribas Financial Markets	34,022	$204K	0.0%	+667.8%	0.079%
11/13/2025	Franklin Resources Inc.	677,587	$4.07M	0.0%	-2.5%	1.567%
11/13/2025	Jefferies Financial Group Inc.	16,300	$98K	0.0%	N/A	0.038%
11/10/2025	TD Asset Management Inc	164,796	$989K	0.0%	-34.7%	0.381%
11/10/2025	Peapod Lane Capital LLC	318,760	$1.91M	1.7%	-19.7%	0.737%
11/7/2025	Vanguard Group Inc.	1,322,625	$7.94M	0.0%	+0.8%	3.058%
11/7/2025	JPMorgan Chase & Co.	6,675	$40K	0.0%	-76.0%	0.015%
11/3/2025	Federated Hermes Inc.	15,158	$91K	0.0%	-65.6%	0.035%
10/21/2025	Capital Advisors Inc. OK	10,000	$60K	0.0%	N/A	0.023%
10/17/2025	Ethic Inc.	15,353	$92K	0.0%	-9.9%	0.035%
Buy These Stocks Before August 31st (Ad) Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwide. The analyst, who called the 2020 crash early, is working with a former NSA codebreaker and Pentagon insider on a new approach to AI stocks ahead of August 31. Investors like Stephen and Keith W. say the tools helped shape their portfolios, though results vary and are not typical. Get the full details on Keith Kaplan's AI stock research now
8/15/2025	Bridgeway Capital Management LLC	62,900	$193K	0.0%	-53.9%	0.145%
8/15/2025	Bank of America Corp DE	33,756	$104K	0.0%	+94.8%	0.078%
8/14/2025	Jane Street Group LLC	87,769	$269K	0.0%	N/A	0.203%
8/14/2025	The Manufacturers Life Insurance Company	118,297	$363K	0.0%	+206.5%	0.274%
8/14/2025	Qube Research & Technologies Ltd	14,051	$43K	0.0%	N/A	0.033%
8/14/2025	Federated Hermes Inc.	44,000	$135K	0.0%	+22.2%	0.102%
8/13/2025	Marshall Wace LLP	62,057	$191K	0.0%	+152.7%	0.144%
8/12/2025	XTX Topco Ltd	34,939	$107K	0.0%	N/A	0.081%
8/12/2025	JPMorgan Chase & Co.	27,855	$86K	0.0%	-29.5%	0.064%
8/12/2025	Catalyst Funds Management Pty Ltd	12,000	$37K	0.0%	N/A	0.028%

KYTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 100 institutional investors and hedge funds held shares of Kyverna Therapeutics. The most heavily invested institutionals were Bain Capital Life Sciences Investors LLC ($29.23M), BlackRock Inc. ($27.93M), AIGH Capital Management LLC ($24.91M), Price T Rowe Associates Inc. MD ($16.57M), Adage Capital Partners GP L.L.C. ($15.67M), Gilead Sciences Inc. ($15.43M), and Balyasny Asset Management L.P. ($9.22M).Learn more on Kyverna Therapeutics' institutional investors.

18.08% of Kyverna Therapeutics' stock is owned by institutional investors. Learn more on KYTX's institutional investor holdings.

Of the 97 institutional investors that purchased Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($4.80M), Gilead Sciences Inc. ($4.13M), BlackRock Inc. ($3.13M), Adage Capital Partners GP L.L.C. ($1.67M), Novo Holdings A S ($1.15M), Balyasny Asset Management L.P. ($980.87K), and Propel Bio Management LLC ($666.67K).

Institutional investors have bought a total of 17,223,518 shares in the last 24 months. This purchase volume represents approximately $154.98M in transactions.

Of the 14 institutional investors that sold Kyverna Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Kera Capital Partners Inc. ($313.84K), Bain Capital Life Sciences Investors LLC ($258.37K), Peapod Lane Capital LLC ($212.94K), TD Asset Management Inc ($87.40K), JPMorgan Chase & Co. ($42.36K), ADAR1 Capital Management LLC ($35K), and Federated Hermes Inc. ($28.84K).

Institutional investors have sold a total of 1,091,673 shares in the last 24 months. This volume of shares sold represents approximately $9.26M in transactions.

Related Companies

Institutional ownership data for NASDAQ:KYTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/17/2026. New 13F filings are added each quarter as they're published.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kyverna Therapeutics (KYTX) Institutional Ownership

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

KYTX Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kyverna Therapeutics (KYTX) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Kyverna Therapeutics (NASDAQ:KYTX)

KYTX Institutional Buying and Selling by Quarter

Kyverna Therapeutics Major Shareholders & Ownership History

KYTX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of KYTX shares?

What percentage of Kyverna Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying Kyverna Therapeutics' stock?

How much institutional buying is happening at Kyverna Therapeutics?

Which of Kyverna Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at Kyverna Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools